位置:首页 > 产品库 > SGD-1882
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
SGD-1882
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
SGD-1882图片
CAS NO:1222490-34-7
包装:1mg
市场价:9450元

SGD-1882 是一种有细胞毒性的 DNA 小沟交联剂,为 PBD 二聚体,可以作为 ADC 的有效载荷。
Cas No.1222490-34-7
别名PBD dimer
分子式C42H39N5O7
分子量725.79
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

SGD-1882 is a cytotoxic, DNA minor-groove crosslinking agent pyrrolobenzodiazepine (PBD) dimer, acting as the payload for ADCs.

SGD-1882 is the cytotoxic payload undergoing clinical evaluation for anti-CD33 and anti-CD70 conjugates[1]. SGD-1882 is not an MDR1 substrate, and SGN-CD33A is conjugated to the SGD-1882. SGN-CD33A can kill MDR1 expressing CD33 positive AML patient samples and is currently in Phase I[2].

[1]. Eunhee G. Kim, et al. Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics. Biomol Ther (Seoul). 2015 Nov; 23(6): 493-509.
[2]. Dowdy Jackson, et al. Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates. Pharm Res. 2015; 32(11): 3458-3469.

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024